SCHEMBL5817533

SCHEMBL5817533

CCCC[n+]1ccn(-c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.49
ALDH1A1 P00352 5/20 0.49
HPGD P15428 1/20 0.49
MAPT P10636 4/20 0.46
HTT P42858 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GLA P06280 1/20 0.46
PKM P14618 1/20 0.46
PABPC1 P11940 1/20 0.44
RXFP1 Q9HBX9 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
APAF1 O14727 2/20 0.43
MITF O75030 1/20 0.43
BLM P54132 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27914237 0.98 KDM4E (0.48) KDM4EALDH1A1HPGDMAPTHTT
Iodide SCHEMBL15992661 0.98 KDM4E (0.48) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL5297789 0.95 KDM4E (0.50) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL5295539 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM
SCHEMBL5297432 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM
SCHEMBL5283301 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM
SCHEMBL5816934 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM
SCHEMBL5301618 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM
SCHEMBL5290628 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM
SCHEMBL5810521 0.94 KDM4E (0.49) KDM4EHTTSMN1; SMN2GLAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 EP disclosed
CN-112703184-A Process for producing amide compound, and amide compound 广荣化学株式会社 2021-04-23 CN disclosed
WO-2020152206-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2020-07-30 WO disclosed
US-10378046-B2 Method of targeting mismatched DNA using d8 square planar metal complexes THE UNIVERSITY OF HONG KONG (CN) 2019-08-13 US disclosed
EP-2254871-B1 SALTS COMPRISING ARYL-ALKYL-SUBSTITUTED IMIDAZOLIUM AND TRIAZOLIUM CATIONS AS IONIC FLUIDS UNIV DRESDEN TECH (DE) 2016-11-09 EP disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM KDM4E 4058/4885ALDH1A1 4082/4885HPGD 2443/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM KDM4E 4058/4885ALDH1A1 4082/4885HPGD 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.